Growth Metrics

Lucid Diagnostics (LUCD) Depreciation and Depletion (2021 - 2022)

Lucid Diagnostics posted quarterly Depreciation and Depletion of $24000.0 for Q1 2022, up 700.0% year-on-year from $3000.0 in Q1 2021, and up 4216.55% on a QoQ basis from $556.0 in Q4 2021.

Lucid Diagnostics (LUCD) has 2 years of Depreciation and Depletion data on file, last reported at $24000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 381.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 120.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 308.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 78.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Lucid Diagnostics 145.00 Mn 117.12 Mn -325,000.00 -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2022 24,000.00
Mar 31, 2022 24,000.00
Dec 31, 2021 556.00
Dec 31, 2021 556.00
Mar 31, 2021 3,000.00
Mar 31, 2021 3,000.00